Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Grade 7: £32,817 - £40,322 p.a.

We are seeking an exceptional and motivated postdoctoral research scientist to study the role of the ubiquitin machinery in inflammation and cancer in vivo. The research within Professor Gyrd-Hansen's group at Ludwig Cancer Research, University of Oxford, is focused on understanding how the ubiquitin system controls innate immune processes that protect against infectious agents but, when inappropriately activated, also contribute to chronic inflammation and cancer. The long-term goal of the work is to identify molecular processes that can be targeted pharmacologically to treat inflammation-driven pathologies, including cancer.

You will have a PhD in immunology, infection biology or a related discipline, a background in cancer biology and experience in experimental murine models. You will design and perform original research using in vivo models and mammalian cell culture systems. It is essential that you will be able and willing to travel to carry out parts of the project at a research institution in the EU.

This post is offered full-time on a 2 year fixed-term contract funded by a Wellcome Trust Fellowship.

Applications must be made online by 12.00 noon (UK time) on 30th March 2020.